Axsome Therapeutics (AXSM) Profit After Tax Growth (5y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.14% |
| Dec 31, 2025 | 0.42% |
| Sep 30, 2025 | -15.55% |
| Jun 30, 2025 | -21.22% |
| Mar 31, 2025 | -12.83% |
| Dec 31, 2024 | -24.74% |
| Sep 30, 2024 | -27.55% |
| Jun 30, 2024 | -41.96% |
| Mar 31, 2024 | -45.07% |
| Dec 31, 2023 | -59.37% |
| Sep 30, 2023 | -49.67% |
| Jun 30, 2023 | -51.99% |
| Mar 31, 2023 | -18.48% |
| Dec 31, 2022 | -52.48% |
| Sep 30, 2022 | -47.44% |
| Jun 30, 2022 | -42.37% |
| Mar 31, 2022 | -37.74% |
| Dec 31, 2021 | -35.90% |
| Sep 30, 2021 | -37.13% |
| Jun 30, 2021 | -36.50% |
| Mar 31, 2021 | -37.91% |
| Dec 31, 2020 | -54.02% |
| Sep 30, 2020 | -38.03% |
| Jun 30, 2020 | -53.80% |
| Mar 31, 2020 | -72.28% |